Evidence map›Paper›PMID 28418387›Full record

ReviewNature immunology2017

Mitochondria are the powerhouses of immunity.

Evanna L Mills, Beth Kelly, Luke A J O'Neill

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05743582 (Analysis of Innate Immune Competence in People With Chronic Obstructive Pulmonary Disease), which is not on this map. Cited by 632 papers.

0numbers the graph read from it
0cells of the map it votes in
632citing papers in PubMed
31.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05743582 recruitingnot on this mapstarted 2023, after this paper: background citation

Analysis of Innate Immune Competence in People With Chronic Obstructive Pulmonary Disease (COPD)

TypeobservationalSponsorUniversity of EdinburghRan2023 to 2028Enrolled189ConditionsChronic Obstructive Pulmonary DiseaseArmsBronchoscopy for sample collection, Blood donation
3 · Its place in the literature

Who cites it

632 citing papers in PubMed, 1,102 citations in OpenAlex.

  1. Review
  2. DRP1 depletion protects NK cells from hypoxia-induced dysfunction.Redox report : communications in free radical research · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Recent advances in understanding chemotherapy-induced fatigue in BC patients residing in high-altitude regions: a review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Review
  14. Article
  15. Article
  16. bioRxiv : the preprint server for biology · 2026
    Article
  17. Article
  18. Review
  19. Article
  20. Article

572 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Evanna L MillsSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Beth KellyDepartment of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Luke A J O'NeillSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Trinity College Dublin · IEMax Planck Institute of Immunobiology and Epigenetics · DE

Funding

Wellcome Trust 109443/Z/15/Z
6 · The paper itself

Abstract

Recent evidence indicates that mitochondria lie at the heart of immunity. Mitochondrial DNA acts as a danger-associated molecular pattern (DAMP), and the mitochondrial outer membrane is a platform for signaling molecules such as MAVS in RIG-I signaling, and for the NLRP3 inflammasome. Mitochondrial biogenesis, fusion and fission have roles in aspects of immune-cell activation. Most important, Krebs cycle intermediates such as succinate, fumarate and citrate engage in processes related to immunity and inflammation, in both innate and adaptive immune cells. These discoveries are revealing mitochondrial targets that could potentially be exploited for therapeutic gain in inflammation and cancer.

Indexed as

Adaptive ImmunityImmunity, InnateAnimalsCitric Acid CycleDEAD Box Protein 58Energy MetabolismHumansImmunomodulationInflammasomesLymphocyte ActivationMitochondriaMitochondrial MembranesNLR Family, Pyrin Domain-Containing 3 ProteinReceptors, ImmunologicReceptors, Pattern RecognitionSignal TransductionDEAD Box Protein 58InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinReceptors, ImmunologicReceptors, Pattern RecognitionRIGI protein, human

Identifiers

PMID28418387
OpenAlexW2606546819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.